4-tert-butyl-N-(3-formylphenyl)benzenesulfonamide, 100mg

N,O-Bis(trimethylsilyl)acetamide Kit BSA 1 mL * 8 / Reaction vial, capacity 2 mL * 8>80.0%(GC)1kit

[2-(1H-tetrazol-5-yl)ethyl]amine hydrobromide, 95.0%, 1g

4-Mercaptobutyric acid, 90.0%, 250mg

2-Acetyl-7-methoxybenzofuran>98.0%(GC)10g

5-Oxo-thiomorpholine-3-carboxylic acid, 1g

3,4-difluoro-4'-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone, 97.0%, 1g

TERT-BUTYL (2-(4-METHYLPIPERAZIN-1-YL)ETHYL)CARBAMATE, 95.0%, 250mg

1H,4H,7H-pyrazolo[4,3-d]pyrimidin-7-one, 98%, 5g

N,N-Bis[(1S)-1-phenylethyl]dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-amine, ?97.0%, 100mg

3-((tert-Butoxycarbonyl)amino)bicyclo[1.1.1]pentane-1-carboxylic acid, 95.0%, 5g

1-Bromo-4-octylbenzene, 95.0%, 5g

4-Acridinecarboxamide, N-[4-[2-(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)ethyl]phenyl]-9,10-dihydro-5-methoxy-9-oxo-, hydrochloride (1:1), 98%, 25mg